SCHEMBL10145472

SCHEMBL10145472

CC(C)(C)c1ccc2c(ccc3c(-c4ccccc4C(=O)O)c4cc(Cl)c(=O)cc-4oc32)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 2/20 0.56
SOS1 Q07889 2/20 0.48
CYP1A1 P04798 6/20 0.44
CYP1B1 Q16678 6/20 0.44
CYP1A2 P05177 5/20 0.44
KDM4E B2RXH2 3/20 0.42
POLB P06746 1/20 0.42
GNG2 P59768 1/20 0.40
GNB1 P62873 1/20 0.40
CYP3A4 P08684 3/20 0.40
TSHR P16473 2/20 0.40
CYP2C19 P33261 2/20 0.40
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
THRB P10828 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
BRCA1 P38398 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15139517 0.86 SOS1 (0.66) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL10175853 0.85 FTO (0.56) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL10145484 0.83 FTO (0.48) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL10145497 0.81 FTO (0.54) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL10145463 0.81 SOS1 (0.72) SOS1KDM4EPOLBGNG2GNB1
SCHEMBL12393718 0.76 FTO (0.64) FTOSOS1KDM4EPOLBGNG2
SCHEMBL2059938 0.75 FTO (0.57) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL13678651 0.74 FTO (0.77) FTOSOS1CYP1B1CYP1A2KDM4E
SCHEMBL10145468 0.74 FTO (0.48) FTOSOS1CYP1A1CYP1B1CYP1A2
SCHEMBL14626814 0.72 FTO (0.59) FTOSOS1KDM4EPOLBGNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114904-B2 Luminescence quenchers and fluorogenic probes for detection of reactive species Versitech Limited & Morningside Ventures Limited (CN) 2012-02-14 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES ROS1, LPO, HMOX1 FTO 244/4885SOS1 1103/4885CYP1A1 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.